245 related articles for article (PubMed ID: 12694759)
1. Pulmonary large-cell neuroendocrine carcinoma (LCNEC).
Hage R; Seldenrijk K; de Bruin P; van Swieten H; van den Bosch J
Eur J Cardiothorac Surg; 2003 Apr; 23(4):457-60. PubMed ID: 12694759
[TBL] [Abstract][Full Text] [Related]
2. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
[TBL] [Abstract][Full Text] [Related]
3. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
[TBL] [Abstract][Full Text] [Related]
4. Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic nodal dissection.
Zacharias J; Nicholson AG; Ladas GP; Goldstraw P
Ann Thorac Surg; 2003 Feb; 75(2):348-52. PubMed ID: 12607637
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma.
Iyoda A; Hiroshima K; Nakatani Y; Fujisawa T
Ann Thorac Surg; 2007 Aug; 84(2):702-7. PubMed ID: 17643676
[TBL] [Abstract][Full Text] [Related]
6. The surgical spectrum of pulmonary neuroendocrine neoplasms.
Cooper WA; Thourani VH; Gal AA; Lee RB; Mansour KA; Miller JI
Chest; 2001 Jan; 119(1):14-8. PubMed ID: 11157578
[TBL] [Abstract][Full Text] [Related]
7. Surgical management of pulmonary large cell neuroendocrine carcinomas: a 10-year experience.
Fournel L; Falcoz PE; Alifano M; Charpentier MC; Boudaya MS; Magdeleinat P; Damotte D; Régnard JF
Eur J Cardiothorac Surg; 2013 Jan; 43(1):111-4. PubMed ID: 22529187
[TBL] [Abstract][Full Text] [Related]
8. [Large cell neuroendocrine carcinoma of the lung].
Mimae T; Yamashita M; Maeda A; Toyosaki R; Suehisa H; Komori E; Sawada S; Kurita A; Takashima S
Kyobu Geka; 2009 Jun; 62(6):442-5. PubMed ID: 19522201
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of large cell neuroendocrine carcinoma: a population-based overview.
Derks JL; Hendriks LE; Buikhuisen WA; Groen HJ; Thunnissen E; van Suylen RJ; Houben R; Damhuis RA; Speel EJ; Dingemans AM
Eur Respir J; 2016 Feb; 47(2):615-24. PubMed ID: 26541538
[TBL] [Abstract][Full Text] [Related]
10. The differences of biological behavior based on the clinicopathological data between resectable large-cell neuroendocrine carcinoma and small-cell lung carcinoma.
Kinoshita T; Yoshida J; Ishii G; Aokage K; Hishida T; Nagai K
Clin Lung Cancer; 2013 Sep; 14(5):535-40. PubMed ID: 23792008
[TBL] [Abstract][Full Text] [Related]
11. The Role of Systemic Therapy in the Management of Stage I Large Cell Neuroendocrine Carcinoma of the Lung.
Kujtan L; Muthukumar V; Kennedy KF; Davis JR; Masood A; Subramanian J
J Thorac Oncol; 2018 May; 13(5):707-714. PubMed ID: 29391287
[TBL] [Abstract][Full Text] [Related]
12. Double primary lung carcinoma consisting of large cell neuroendocrine carcinoma and squamous cell carcinoma: report of a case.
Yamada Y; Iyoda A; Suzuki M; Mizobuchi T; Baba M; Hiroshima K; Ohwada H; Fujisawa T
Ann Thorac Cardiovasc Surg; 2005 Dec; 11(6):397-400. PubMed ID: 16401989
[TBL] [Abstract][Full Text] [Related]
13. Predictors of survival after operation among patients with large cell neuroendocrine carcinoma of the lung.
Eichhorn F; Dienemann H; Muley T; Warth A; Hoffmann H
Ann Thorac Surg; 2015 Mar; 99(3):983-9. PubMed ID: 25596870
[TBL] [Abstract][Full Text] [Related]
14. Treatment options for patients with large cell neuroendocrine carcinoma of the lung.
Iyoda A; Makino T; Koezuka S; Otsuka H; Hata Y
Gen Thorac Cardiovasc Surg; 2014 Jun; 62(6):351-6. PubMed ID: 24719260
[TBL] [Abstract][Full Text] [Related]
15. [Prognosis of surgically treated large cell neuroendocrine carcinoma].
Matsuura N; Nakashima N; Igai H; Tarumi S; Chang SS; Misaki N; Liu D; Go T; Ishikawa S; Huang CL; Yokomise H
Kyobu Geka; 2011 Mar; 64(3):187-90. PubMed ID: 21404553
[TBL] [Abstract][Full Text] [Related]
16. A Single-Institution Analysis of the Surgical Management of Pulmonary Large Cell Neuroendocrine Carcinomas.
Roesel C; Terjung S; Weinreich G; Gauler T; Theegarten D; Stamatis G; Welter S
Ann Thorac Surg; 2016 May; 101(5):1909-14. PubMed ID: 26897321
[TBL] [Abstract][Full Text] [Related]
17. High grade neuroendocrine lung tumors: pathological characteristics, surgical management and prognostic implications.
Grand B; Cazes A; Mordant P; Foucault C; Dujon A; Guillevin EF; Barthes FLP; Riquet M
Lung Cancer; 2013 Sep; 81(3):404-409. PubMed ID: 23769675
[TBL] [Abstract][Full Text] [Related]
18. Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.
Zhang JT; Li Y; Yan LX; Zhu ZF; Dong XR; Chu Q; Wu L; Zhang HM; Xu CW; Lin G; Yu ZY; Hu J; Zhu B; Wang HJ; Yang F; Song ZB; Han ZB; Li MX; Lin J; Wu YL; Wang JL; Zhong WZ
Lung Cancer; 2020 Jan; 139():118-123. PubMed ID: 31775086
[TBL] [Abstract][Full Text] [Related]
19. Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes.
Naidoo J; Santos-Zabala ML; Iyriboz T; Woo KM; Sima CS; Fiore JJ; Kris MG; Riely GJ; Lito P; Iqbal A; Veach S; Smith-Marrone S; Sarkaria IS; Krug LM; Rudin CM; Travis WD; Rekhtman N; Pietanza MC
Clin Lung Cancer; 2016 Sep; 17(5):e121-e129. PubMed ID: 26898325
[TBL] [Abstract][Full Text] [Related]
20. MGMT promoter methylation and 1p/19q co-deletion of surgically resected pulmonary carcinoid and large-cell neuroendocrine carcinoma.
Lei L; Jiang Z; Zhang G; Cheng Q; Lu H
World J Surg Oncol; 2018 Jun; 16(1):110. PubMed ID: 29914531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
